| 000 | 01798 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515190733.0 | ||
| 264 | 0 | _c20091222 | |
| 008 | 200912s 0 0 eng d | ||
| 022 | _a1878-3554 | ||
| 024 | 7 |
_a10.1016/j.joen.2009.06.022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe-Deus, Gustavo | |
| 245 | 0 | 0 |
_aOptimal cytocompatibility of a bioceramic nanoparticulate cement in primary human mesenchymal cells. _h[electronic resource] |
| 260 |
_bJournal of endodontics _cOct 2009 |
||
| 300 |
_a1387-90 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAluminum Compounds _xpharmacology |
| 650 | 0 | 4 |
_aBiocompatible Materials _xtoxicity |
| 650 | 0 | 4 |
_aCalcium Compounds _xpharmacology |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCeramics _xchemistry |
| 650 | 0 | 4 | _aColoring Agents |
| 650 | 0 | 4 | _aCulture Media |
| 650 | 0 | 4 | _aCulture Media, Conditioned |
| 650 | 0 | 4 |
_aDental Cements _xtoxicity |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMaterials Testing |
| 650 | 0 | 4 |
_aMesoderm _xcytology |
| 650 | 0 | 4 |
_aNanoparticles _xchemistry |
| 650 | 0 | 4 |
_aOxides _xpharmacology |
| 650 | 0 | 4 | _aRetrograde Obturation |
| 650 | 0 | 4 |
_aRoot Canal Filling Materials _xtoxicity |
| 650 | 0 | 4 |
_aSilicates _xpharmacology |
| 650 | 0 | 4 | _aTetrazolium Salts |
| 650 | 0 | 4 | _aThiazoles |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aCanabarro, Antonio | |
| 700 | 1 | _aAlves, Gutemberg | |
| 700 | 1 | _aLinhares, Adriana | |
| 700 | 1 | _aSenne, Maria Isabel | |
| 700 | 1 | _aGranjeiro, Jose Mauro | |
| 773 | 0 |
_tJournal of endodontics _gvol. 35 _gno. 10 _gp. 1387-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.joen.2009.06.022 _zAvailable from publisher's website |
| 999 |
_c19196577 _d19196577 |
||